Skip to main content
OpenTrials

Clinical trial condition

Disease Attributes

Explore clinical trials studying Disease Attributes. Study availability and eligibility vary by location and protocol.

21,697 public trials 3,130 recruiting studies
Refine in advanced search Browse all conditions

Disease Attributes trial results

Recruiting

Study of Out of Specification for Tisagenlecleucel

NCT04094311

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +25 more
Locations
  • Novartis Investigative Site Hamilton, Ontario, Canada
  • Novartis Investigative Site Ottawa, Ontario, Canada
  • Novartis Investigative Site Toronto, Ontario, Canada
  • Novartis Investigative Site Toronto, Ontario, Canada
View all 55 locations
View Trial Details
Recruiting

Study of Olverembatinib (HQP1351) in Patients With CML-CP

NCT06423911

Conditions
Bone Marrow Diseases, CML, CML, Chronic Phase, +14 more
Locations
  • Ascentage Investigative Site #1044 Birmingham, Alabama, United States
  • Ascentage Investigative Site #1112 Anchorage, Alaska, United States
  • Ascentage Investigative Site #1111 Goodyear, Arizona, United States
  • Ascentage Investigative Site #1062 Duarte, California, United States
View all 163 locations
View Trial Details
Recruiting

A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

NCT07067463

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Arizona Neuroscience Research, LLC Pheonix, Arizona, United States
  • Perseverance Research Center Scottsdale, Arizona, United States
  • Regina Berkovich MD, PhD Inc. West Hollywood, California, United States
  • Nova Clinical Research, LLC Bradenton, Florida, United States
View all 63 locations
View Trial Details
Recruiting

Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

NCT05798897

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +18 more
Locations
  • City of Hope Duarte, California, United States
  • University of Colorado Aurora, Colorado, United States
  • Colorado Blood Cancer Institute (Sarah Cannon) Denver, Colorado, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
View Trial Details

Related conditions